Fluid intake and blood pressure in children: the Salus per Aquam project.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
01 01 2022
Historique:
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 28 1 2022
Statut: ppublish

Résumé

Sodium intake is known to contribute to the development of hypertension, thus intake reduction is a cornerstone in the prevention and management of hypertension. The increase in renal sodium excretion might represent a further potential preventive and/or therapeutic opportunity. To explore the working hypothesis that an increased fluid intake can improve renal sodium handling towards a decrease in blood pressure. The SPA Project is a multicenter, observational, cross-sectional, cohort study investigating healthy children, aged 5-8 years as to sodium and fluid intake by means of urinary sodium and creatinine from multiple samples taken in different days in order to characterize them in lower/higher sodium and lower/higher fluid intake. Both SBP and DBP (by multiple office blood pressure measurements) were used as outcome measures. Three hundred and thirty-nine healthy, nonoverweight children (51.6% boys) with a median age of 5.7 years old (IQR: 5.3-6.2) participated in the study but only 223 could be analyzed. Among children with higher sodium intake, those introducing more fluids, showed a significantly lower blood pressure (both systolic and diastolic) compared with those with lower fluid intake: systolic 86.0 ± 8.5 vs. 90.0 ± 8.1 mmHg; P = 0.014 and diastolic: 53.8 ± 4.9 vs. 58.6 ± 6.6 mmHg; P < 0.0001. An increased fluid intake is associated with a reduced blood pressure possibly by increasing renal sodium excretion. We speculate that this simple, highly acceptable, inexpensive, and harmless measure might have a role in preventing and/or minimizing the epidemics of hypertension and of its related morbidities both in children and in adults.

Sections du résumé

BACKGROUND
Sodium intake is known to contribute to the development of hypertension, thus intake reduction is a cornerstone in the prevention and management of hypertension. The increase in renal sodium excretion might represent a further potential preventive and/or therapeutic opportunity.
OBJECTIVE
To explore the working hypothesis that an increased fluid intake can improve renal sodium handling towards a decrease in blood pressure.
METHODS
The SPA Project is a multicenter, observational, cross-sectional, cohort study investigating healthy children, aged 5-8 years as to sodium and fluid intake by means of urinary sodium and creatinine from multiple samples taken in different days in order to characterize them in lower/higher sodium and lower/higher fluid intake. Both SBP and DBP (by multiple office blood pressure measurements) were used as outcome measures.
RESULTS
Three hundred and thirty-nine healthy, nonoverweight children (51.6% boys) with a median age of 5.7 years old (IQR: 5.3-6.2) participated in the study but only 223 could be analyzed. Among children with higher sodium intake, those introducing more fluids, showed a significantly lower blood pressure (both systolic and diastolic) compared with those with lower fluid intake: systolic 86.0 ± 8.5 vs. 90.0 ± 8.1 mmHg; P = 0.014 and diastolic: 53.8 ± 4.9 vs. 58.6 ± 6.6 mmHg; P < 0.0001.
CONCLUSION
An increased fluid intake is associated with a reduced blood pressure possibly by increasing renal sodium excretion. We speculate that this simple, highly acceptable, inexpensive, and harmless measure might have a role in preventing and/or minimizing the epidemics of hypertension and of its related morbidities both in children and in adults.

Identifiants

pubmed: 34857709
doi: 10.1097/HJH.0000000000002992
pii: 00004872-202201000-00021
doi:

Substances chimiques

Sodium 9NEZ333N27

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-179

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
Oparil S, Acelajado MC, Bakris GL, et al. Hypertension. Nat Rev Dis Primers 2018; 22:18014.
Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013; 23:e003733.
He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomized trials. BMJ 2013; 346:325.
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3–10.
Ardissino G, Ghiglia S, Salice P, Perrone M, Piantanida S, De Luca FL, et al. SPA Project investigators. Multiple office blood pressure measurement: a novel approach to overcome the weak cornerstone of blood pressure measurement in children. Data from the SPA project. Pediatr Nephrol 2020; 35:687–693.
Tseng E, Appel LJ, Yeh HC, Pilla SJ, Miller ER, Juraschek SP, Maruthur NM. Effects of the dietary approaches to stop hypertension diet and sodium reduction on blood pressure in persons with diabetes. Hypertension 2021; 77:265–274.
[2008–2013] Action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2008.
Asaria P, Chrisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control of tobacco use. Lancet 2007; 370:2044–2053.
Kloss L, Meyer JD, Groeve L, Vetter W. Sodium intake and its reduction by food reformulation in the European Union – a review. NFS Journal 2015; 1:9–19.
Rios-Leyvraz M, Bovet P, Chiolero A. Estimating the effect of a reduction of sodium intake in childhood on cardiovascular diseases later in life. J Hum Hypertens 2020; 34:335–337.
Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995; 155:701–709.
Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, et al. Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: the CKD WIT Randomized Clinical Trial. JAMA 2018; 319:1870–1879.
Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, et al. Hemodynamic and neuroendocrine response to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006; 290:1294–1301.
Damgaard M, Gabrielsen A, Heer M, Warberg J, Bie P, Christensen NJ, Norsk P. Effect of sodium intake on cardiovascular variables in humans during posture changes and ambulatory conditions. Am J Physiol Regul Intergr Comp Physiol 2002; 283:R1404–R1411.
Bankir L, Perucca J, Norsk P, Bouby N, Damgaard M. Relationship between sodium intake and water intake: the false and the true. Ann Nutr Metab 2017; 70 Suppl 1:51–61.
He FJ, Markandu ND, Sagnella GA, Mac Gregor. Effect of salt intake on renal excretion of water in humans. Hypertension 2001; 38:317–320.
Choukroun G, Schmitt F, Martinez F, Drueke TB, Bankir L. Low urine flow reduces the capacity to excrete a sodium load in humans. Am J Physiol 1997; 273:R1726–R1733.
Eriksson L, Valtonen M, Makela J. Water and electrolyte balance in male mink on varying dietary NaCL intake. Acta Physiol Scand 1984; 537:59–64.
McLean R, Williams S, Mann J. Monitoring population sodium intake using spot urine samples: validation in a New Zealand population. J Hum Hypertens 2014; 28:657–662.
McLean RM. Measuring population sodium intake: a review of methods. Nutrients 2014; 28:4651–4662.
Schoen T, Blum J, Paccaud F, Burnier M, Bochud M, Conen D. Swiss Survey on Salt investigators. Factors associated with 24-h urinary volume: the Swiss salt survey. BMC Nephrol 2013; 14:246–247.
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–2100.
Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983; 309:1543–1546.
Ardissino G, Vergori A, Vergori C, Martelli L, Daccò V, Villa MC, et al. Multiple, random spot urine sampling for estimating urinary sodium excretion. Eur J Pediatr 2021; doi: 10.1007/s00431-021-04170-4 [Epub ahead of print].
doi: 10.1007/s00431-021-04170-4
Iwahori T, Miura K, Ueshima H, Tanaka-Mizuno S, Chan Q, Arima H, et al. INTERSALT Research Group. Urinary sodium-to-potassium ratio and intake of sodium and potassium among men and women from multiethnic general populations: the INTERSALT Study. Hypertens Res 2019; 42:1590–1598.
Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, et al. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Hypertens Res 2010; 33:850–856.
Stanhewicz AE, Kenney WL. Determinants of water and sodium intake and output. Nutrition Review 2019; 73 Suppl 2:73–82.
He FJ, Tan M, Ma Y, MacGregor GA. Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol 2020; 75:632–647.

Auteurs

Gianluigi Ardissino (G)

Pediatric Nephrology, Dialysis and Transplantation Unit.

Michela Perrone (M)

Neonatology and Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Silvia Ghiglia (S)

Department of Pediatric Cardiology, Vittore Buzzi Children's Hospital.

Patrizia Salice (P)

Pediatric Cardiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico.

Francesca Tel (F)

Department of Pediatrics, Vittore Buzzi Children's Hospital.

Elena Dardi (E)

Pediatric Practitioner, Milan, Italy.

Tiziana Bollani (T)

Pediatric Practitioner, Milan, Italy.

Antonella Mezzopane (A)

Pediatric Practitioner, Milan, Italy.

Valentina Capone (V)

Pediatric Nephrology, Dialysis and Transplantation Unit.

Maddalena Ardissino (M)

Department of Medicine, Imperial College, London, UK.

Antonio Vergori (A)

Pediatric Nephrology, Dialysis and Transplantation Unit.

Sandra Piantanida (S)

UO Cardiologia ad Indirizzo Pediatrico, Polo Materno-Infantile, Varese.

Silvia Di Michele (S)

UOC Pediatria Medica, Ospedale di Pescara, Pescara.

Bertrand Tchana (B)

Pediatric Cardiology Unit, Parma General and University Hospital, Parma.

Lucia Filippucci (L)

UO Cardiologia Riabilitativa e Prevenzione Patologie Cardiovascolari, USL Umbria1, Perugia.

Francesco De Luca (F)

UOS Cardiologia Pediatrica, Policlinico Universitario, Messina.

Dario Consonni (D)

Epidemiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.

Roberto Buzzetti (R)

Freelance Clinical Epidemiologist, Bergamo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH